↓ Skip to main content

11q deletion in neuroblastoma: a review of biological and clinical implications

Overview of attention for article published in Molecular Cancer, June 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)

Mentioned by

twitter
2 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
11q deletion in neuroblastoma: a review of biological and clinical implications
Published in
Molecular Cancer, June 2017
DOI 10.1186/s12943-017-0686-8
Pubmed ID
Authors

Vid Mlakar, Simona Jurkovic Mlakar, Gonzalo Lopez, John M. Maris, Marc Ansari, Fabienne Gumy-Pause

Abstract

Deletion of the long arm of chromosome 11 (11q deletion) is one of the most frequent events that occur during the development of aggressive neuroblastoma. Clinically, 11q deletion is associated with higher disease stage and decreased survival probability. During the last 25 years, extensive efforts have been invested to identify the precise frequency of 11q aberrations in neuroblastoma, the recurrently involved genes, and to understand the molecular mechanisms of 11q deletion, but definitive answers are still unclear. In this review, it is our intent to compile and review the evidence acquired to date on 11q deletion in neuroblastoma.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 96 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 17%
Student > Bachelor 16 17%
Researcher 10 10%
Student > Master 8 8%
Student > Postgraduate 5 5%
Other 12 13%
Unknown 29 30%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 30 31%
Medicine and Dentistry 15 16%
Agricultural and Biological Sciences 9 9%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Computer Science 3 3%
Other 4 4%
Unknown 30 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 November 2019.
All research outputs
#6,175,731
of 20,888,897 outputs
Outputs from Molecular Cancer
#385
of 1,581 outputs
Outputs of similar age
#95,154
of 283,248 outputs
Outputs of similar age from Molecular Cancer
#1
of 1 outputs
Altmetric has tracked 20,888,897 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 1,581 research outputs from this source. They receive a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,248 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them